Frequency Short Term Debt vs Current Deferred Revenue Analysis

KRRO Stock

52.31 1.69 3.34%

Frequency Therapeutics financial indicator trend analysis is much more than just examining Frequency Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Frequency Therapeutics is a good investment. Please check the relationship between Frequency Therapeutics Short Term Debt and its Current Deferred Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.

Short Term Debt vs Current Deferred Revenue

Short Term Debt vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Frequency Therapeutics Short Term Debt account and Current Deferred Revenue. At this time, the significance of the direction appears to have pay attention.

The correlation between Frequency Therapeutics' Short Term Debt and Current Deferred Revenue is -0.93. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Frequency Therapeutics, assuming nothing else is changed. The correlation between historical values of Frequency Therapeutics' Short Term Debt and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Frequency Therapeutics are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Short Term Debt i.e., Frequency Therapeutics' Short Term Debt and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-0.93

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Short Term Debt

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Frequency Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Frequency Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.At this time, Frequency Therapeutics' Enterprise Value Over EBITDA is very stable compared to the past year. As of the 25th of November 2024, Enterprise Value Multiple is likely to grow to 0.75, while Tax Provision is likely to drop about 14.3 K.

	2023	2024 (projected)
Interest Expense	106.2K	106.1K
Depreciation And Amortization	3.6M	2.1M

Interest Expense Depreciation And Amortization

Frequency Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Net Receivables	Current Deferred Revenue	Other Assets	Short Term Investments	Short Term Debt	Inventory
Total Assets		-0.2	0.79	0.84	0.87	0.74	-0.97	-0.72	0.7	0.99	0.73	-0.01	0.99	0.27	-0.13	0.85	0.87	0.14	0.99	0.53	0.53	-0.61	-0.39	0.04	0.4	0.49
Short Long Term Debt Total	-0.2		-0.31	-0.14	-0.07	-0.34	0.3	0.44	-0.3	-0.11	-0.38	-0.1	-0.15	0.01	-0.28	-0.33	-0.21	-0.35	-0.16	0.2	0.07	0.56	0.25	0.16	-0.65	-0.26
Other Current Liab	0.79	-0.31		0.5	0.8	0.96	-0.76	-0.96	0.95	0.74	0.96	0.17	0.73	0.32	-0.1	0.98	0.92	0.06	0.74	0.09	0.02	-0.73	-0.84	-0.4	0.6	0.83
Total Current Liabilities	0.84	-0.14	0.5		0.8	0.4	-0.91	-0.49	0.4	0.88	0.39	0.16	0.88	-0.02	-0.36	0.64	0.73	-0.05	0.88	0.71	0.87	-0.22	-0.24	-0.06	0.1	0.25
Total Stockholder Equity	0.87	-0.07	0.8	0.8		0.77	-0.9	-0.71	0.77	0.91	0.75	0.32	0.86	0.05	-0.55	0.87	0.96	-0.32	0.87	0.6	0.49	-0.32	-0.6	-0.27	0.1	0.59
Property Plant And Equipment Net	0.74	-0.34	0.96	0.4	0.77		-0.71	-0.92	0.98	0.69	1.0	0.27	0.67	0.18	-0.13	0.94	0.89	0.0	0.67	0.15	-0.08	-0.7	-0.78	-0.33	0.52	0.78
Net Debt	-0.97	0.3	-0.76	-0.91	-0.9	-0.71		0.72	-0.67	-0.97	-0.7	-0.1	-0.97	-0.17	0.22	-0.85	-0.89	-0.07	-0.97	-0.58	-0.63	0.54	0.45	0.06	-0.37	-0.46
Retained Earnings	-0.72	0.44	-0.96	-0.49	-0.71	-0.92	0.72		-0.95	-0.66	-0.94	-0.33	-0.65	-0.13	0.07	-0.96	-0.87	-0.09	-0.66	-0.02	-0.01	0.7	0.82	0.53	-0.64	-0.86
Accounts Payable	0.7	-0.3	0.95	0.4	0.77	0.98	-0.67	-0.95		0.66	0.99	0.39	0.62	0.07	-0.19	0.94	0.89	-0.06	0.63	0.13	-0.08	-0.63	-0.83	-0.47	0.48	0.82
Cash	0.99	-0.11	0.74	0.88	0.91	0.69	-0.97	-0.66	0.66		0.67	0.05	0.99	0.2	-0.24	0.81	0.87	0.04	0.99	0.63	0.61	-0.5	-0.36	0.04	0.27	0.44
Non Current Assets Total	0.73	-0.38	0.96	0.39	0.75	1.0	-0.7	-0.94	0.99	0.67		0.28	0.65	0.17	-0.1	0.94	0.88	0.02	0.66	0.11	-0.1	-0.72	-0.8	-0.37	0.56	0.79
Non Currrent Assets Other	-0.01	-0.1	0.17	0.16	0.32	0.27	-0.1	-0.33	0.39	0.05	0.28		-0.05	-0.84	-0.66	0.27	0.35	-0.65	-0.05	0.25	0.04	0.34	-0.34	-0.69	-0.34	0.35
Cash And Short Term Investments	0.99	-0.15	0.73	0.88	0.86	0.67	-0.97	-0.65	0.62	0.99	0.65	-0.05		0.28	-0.14	0.81	0.84	0.14	1.0	0.58	0.62	-0.56	-0.35	0.08	0.36	0.41
Common Stock Shares Outstanding	0.27	0.01	0.32	-0.02	0.05	0.18	-0.17	-0.13	0.07	0.2	0.17	-0.84	0.28		0.49	0.19	0.09	0.51	0.28	-0.37	-0.15	-0.59	-0.17	0.29	0.56	0.19
Non Current Liabilities Total	-0.13	-0.28	-0.1	-0.36	-0.55	-0.13	0.22	0.07	-0.19	-0.24	-0.1	-0.66	-0.14	0.49		-0.19	-0.41	0.95	-0.14	-0.51	-0.37	-0.57	0.24	0.47	0.67	-0.24
Other Current Assets	0.85	-0.33	0.98	0.64	0.87	0.94	-0.85	-0.96	0.94	0.81	0.94	0.27	0.81	0.19	-0.19		0.97	0.01	0.81	0.23	0.19	-0.66	-0.8	-0.41	0.53	0.79
Other Stockholder Equity	0.87	-0.21	0.92	0.73	0.96	0.89	-0.89	-0.87	0.89	0.87	0.88	0.35	0.84	0.09	-0.41	0.97		-0.2	0.84	0.42	0.34	-0.48	-0.74	-0.39	0.31	0.74
Total Liab	0.14	-0.35	0.06	-0.05	-0.32	0.0	-0.07	-0.09	-0.06	0.04	0.02	-0.65	0.14	0.51	0.95	0.01	-0.2		0.14	-0.31	-0.11	-0.68	0.18	0.48	0.76	-0.18
Total Current Assets	0.99	-0.16	0.74	0.88	0.87	0.67	-0.97	-0.66	0.63	0.99	0.66	-0.05	1.0	0.28	-0.14	0.81	0.84	0.14		0.58	0.61	-0.56	-0.35	0.07	0.36	0.42
Common Stock	0.53	0.2	0.09	0.71	0.6	0.15	-0.58	-0.02	0.13	0.63	0.11	0.25	0.58	-0.37	-0.51	0.23	0.42	-0.31	0.58		0.78	0.18	0.13	0.29	-0.43	-0.24
Net Receivables	0.53	0.07	0.02	0.87	0.49	-0.08	-0.63	-0.01	-0.08	0.61	-0.1	0.04	0.62	-0.15	-0.37	0.19	0.34	-0.11	0.61	0.78		0.16	0.19	0.17	-0.24	-0.18
Current Deferred Revenue	-0.61	0.56	-0.73	-0.22	-0.32	-0.7	0.54	0.7	-0.63	-0.5	-0.72	0.34	-0.56	-0.59	-0.57	-0.66	-0.48	-0.68	-0.56	0.18	0.16		0.44	-0.09	-0.93	-0.46
Other Assets	-0.39	0.25	-0.84	-0.24	-0.6	-0.78	0.45	0.82	-0.83	-0.36	-0.8	-0.34	-0.35	-0.17	0.24	-0.8	-0.74	0.18	-0.35	0.13	0.19	0.44		0.71	-0.42	-0.8
Short Term Investments	0.04	0.16	-0.4	-0.06	-0.27	-0.33	0.06	0.53	-0.47	0.04	-0.37	-0.69	0.08	0.29	0.47	-0.41	-0.39	0.48	0.07	0.29	0.17	-0.09	0.71		-0.06	-0.72
Short Term Debt	0.4	-0.65	0.6	0.1	0.1	0.52	-0.37	-0.64	0.48	0.27	0.56	-0.34	0.36	0.56	0.67	0.53	0.31	0.76	0.36	-0.43	-0.24	-0.93	-0.42	-0.06		0.45
Inventory	0.49	-0.26	0.83	0.25	0.59	0.78	-0.46	-0.86	0.82	0.44	0.79	0.35	0.41	0.19	-0.24	0.79	0.74	-0.18	0.42	-0.24	-0.18	-0.46	-0.8	-0.72	0.45

Click cells to compare fundamentals

Frequency Therapeutics Account Relationship Matchups

Frequency Therapeutics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	223.2M	264.7M	127.6M	73.7M	221.7M	153.3M
Other Current Liab	3.4M	6.7M	4.2M	3.2M	10.2M	10.7M
Total Current Liabilities	52.8M	26.6M	4.9M	8.7M	19.5M	18.6M
Total Stockholder Equity	167.4M	192.5M	(42.2M)	(99.0M)	169.9M	178.4M
Property Plant And Equipment Net	1.8M	37.8M	7.1M	11.9M	42.8M	45.0M
Net Debt	(200.2M)	(174.3M)	(37.9M)	(33.2M)	(132.9M)	(126.3M)
Retained Earnings	(68.9M)	(95.4M)	(43.8M)	(101.8M)	(183.0M)	(173.9M)
Accounts Payable	1.2M	5.5M	789K	2.6M	7.3M	7.6M
Cash	200.2M	220.3M	83.5M	36.3M	166.2M	120.5M
Non Current Assets Total	1.9M	39.7M	7.8M	16.7M	48.9M	51.4M
Non Currrent Assets Other	101.0K	(1.0)	(12.8M)	228K	2.7M	2.8M
Cash And Short Term Investments	217.4M	220.3M	118.5M	55.2M	166.2M	131.6M
Common Stock Shares Outstanding	616.9K	645.1K	4.4M	255.2K	1.5M	1.4M
Liabilities And Stockholders Equity	223.2M	264.7M	127.6M	73.7M	221.7M	153.3M
Non Current Liabilities Total	3.1M	45.6M	164.8M	164.1M	32.3M	30.7M
Other Current Assets	3.2M	4.4M	1.2M	1.8M	6.6M	6.9M
Other Stockholder Equity	236.2M	287.8M	1.6M	2.8M	352.9M	370.6M
Total Liab	55.9M	72.2M	169.8M	172.8M	51.8M	49.2M
Total Current Assets	221.4M	225.1M	119.8M	57.1M	172.7M	134.7M
Common Stock	14K	31K	34K	5K	8K	7.2K

Pair Trading with Frequency Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Frequency Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Frequency Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Frequency Stock

0.67	MTEM	Molecular Templates	Pair Corr
0.58	ME	23Andme Holding	Pair Corr
0.57	TPST	Tempest Therapeutics	Pair Corr
0.53	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.5	A	Agilent Technologies Earnings Call Today	Pair Corr

The ability to find closely correlated positions to Frequency Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Frequency Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Frequency Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Frequency Therapeutics to buy it.

The correlation of Frequency Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Frequency Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Frequency Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Frequency Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Frequency Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Frequency Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Frequency Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Frequency Therapeutics Stock:

How To Invest In Frequency

Details

Is Frequency Stock a good investment?

Details

What is Frequency Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(9.42)

Return On Assets

(0.35)

Return On Equity

(0.75)

The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Frequency Short Term Debt vs Current Deferred Revenue Analysis

Short Term Debt vs Current Deferred Revenue

Short Term Debt vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Short Term Debt

Current Deferred Revenue

Frequency Therapeutics fundamental ratios Correlations

Frequency Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Frequency Therapeutics fundamental ratios Accounts

Pair Trading with Frequency Therapeutics

Moving against Frequency Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Accounts Payable

Total Current Assets	- 0.97	Net Debt
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.97	Total Assets
Other Current Assets	- 0.96	Retained Earnings
Retained Earnings	- 0.96	Other Current Liab